EMA recommends Moderna’s updated Omicron-tailored vaccine
The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Moderna says Omicron booster response stays high through three months
The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron
Hong Kong approves baby version of BioNTech vaccine for toddlers
The government has said that each shot contains one-tenth of the adult dosage, reducing the chance of side effects
VINS Bioproducts completes phase-II clinical trials for COVID-19 antidote VINCOV-19
VINCOV-19 is now ready for market authorisation and for simultaneous phase-III clinical trials
Pfizer COVID vaccine clears Japan panel for use with young children
Japan in January expanded use of the vaccine to those as young as five years old
Indonesia approves Chinese mRNA COVID vaccine
The approval comes as somewhat of a surprise as Walvax, which has been conducting large late-stage trials of the vaccine in…
EU recommends marketing approval for Evusheld to treat COVID-19
Recommendation based on Tackle phase-III treatment data showing reduced risk of severe COVID-19 or death
Singapore grants interim approval for Moderna’s bivalent COVID-19 booster vaccine
The vaccine has been authorised for use as a booster shot in individuals aged 18 years and above who have received the primary…
AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures
AstraZeneca's vaccine has struggled to compete globally with those from Pfizer Inc/BioNTech SE and Moderna Inc, whose shots use…
Bharat Biotech seeks drug regulator’s nod for Incovacc’s phase-III study in five-18 age…
Incovacc is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein
Zenara Pharma launches Paxlovid generic for COVID-19 in India
The drug reduces the risk of death or hospitalisation by 89 per cent
DCGI gives EUA to India’s first nasal vaccine against COVID-19
BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
US plans to move COVID vaccines and treatments to private markets in 2023
President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by…
IDRS Labs seeks emergency nod for plant-based drug against long COVID
A tripartite Memorandum of Agreement was signed among BARC, ACTREC-TMC and IDRS to develop Chlorophyllin against COVID-19 disease…
New generation of COVID vaccine shows promising results
As per a study, published in the journal 'EMBO Molecular Medicine,' the vaccine showed promising results in mice, and the…
Thai king’s medical firm reports record profit after vaccine deal with AstraZeneca
The company is part of King Maha Vajiralongkorn's vast fortune, which includes land and property estimated at between $30 billion…
Pfizer-BioNTech COVID shot 73.2 per cent effective in kids aged under five years, reveals new data
The updated data released yesterday showed 13 children had COVID-19, at least seven days after receiving a third dose of the…
Moderna to supply 12 million doses of Omicron-targetted COVID shot to Canada
The Canadian government had entered into a supply deal with the company last year for supply of its COVID vaccine for 2022 and…
COVID mRNA vaccines safe in patients with heart failure, shows study
The study, presented at ESC Congress 2022, found that the vaccines were not associated with an increased risk of worsening heart…
US FDA grants EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents aged 12 through 17 years
Novavax vaccine is the first protein-based COVID-19 vaccine authorised in the US